VF Corp (NYSE:VFC) (CNBC)
The parent company of The North Face and Vans, VF Corp., on Friday reported earnings and sales that fell short of analysts’ expectations. It also revealed plans to sell its Nautica business. Though the news wasn’t taken lightly on Wall Street, CEO Steve Rendle, who’s been at the helm of the North Carolina-based house of brands for about a year now, told CNBC it’s all part of VF’s goal to become a more consumer-facing business and focus on the best labels. VF also owns Timberland, Wrangler and Lee, among a handful of other apparel and footwear banners. VF’s shares dropped more than 8 percent Friday afternoon, having climbed more than 50 percent from a year ago.
Mulesoft Inc (NYSE:MULE) (The Motley Fool)
What happened: Shares of information technology company MuleSoft (NYSE:MULE) climbed as much as 16.7% on Friday. The stock’s gain follows MuleSoft’s fourth-quarter earnings release. Mulesoft shares are up 15.2% at the time of this writing. Optimism toward the stock on Friday likely reflects the company’s higher-than-expected fourth-quarter revenue, as well management’s promising outlook for 2018. “Robust market demand and strong sales execution enabled us to deliver fourth quarter and fiscal 2017 revenue well ahead of expectations,” said MuleSoft CEO Greg Schott about the results.
United States Steel Corporation (NYSE:X) (MarketWatch)
Shares of U.S. Steel Corp. X, +9.85% surged more than 12% and Alcoa Inc. AA, +0.84% stock rose nearly 3% on Friday after the U.S. Commerce Department recommended tariffs on steel and aluminum from other countries, including China and Brazil. U.S. Steel shares were recently up 10% to $43, on track for their their highest close since September 2014. The tariffs and quotas would vary from country to country, with the highest ones going to aluminum from China and Russia, among other countries, and the highest steel tariffs on imports from countries including Brazil, China and Russia.
Apricus Biosciences Inc (NASDAQ:APRI) (Benzinga)
Apricus Biosciences Inc shares tumbled 63.5 percent to $1.16 after the nano-cap pharmaceutical company that focuses on products in the areas of urology and rheumatology announced a disappointing update. The company said that the U.S. Food and Drug Administration won’t approve the company’s cream for the treatment of erectile dysfunction called Vitaros due to “deficiencies related to Chemistry, Manufacturing and Control (“CMC”) and certain safety concerns.”
Sleep Number Corp (NASDAQ:SNBR) (CNBC)
Sleep Number – Sleep Number came in 14 cents a share above estimates, with adjusted quarterly profit of 33 cents per share. The mattress seller also saw revenue beat forecasts. Sleep Number – the company formerly known as Select Comfort – saw its results helped by sales of its 360 Smart Bed, which was introduced in mid-2017.